📰 Pilot Implementation Policy News

Pilot Implementation Policy News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Pilot Implementation Policy. Real-time updates on events, politics, business and more.

CANbridge Announces Marketing Approval of CAN108 (迈芮倍®/LIVMARLI®) in China for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome

June 2, 2023

LIVMARLI First and Only Treatment Approved in Mainland China for Cholestatic Pruritus in ALGS CANbridge to Hold Investor CallBEIJING & BURLINGTON, Mass. ...

United States Hepatol Comms Pediatr Gastroenterol Nutr Chris Brinzey Clin Genet James Xue

Source: oilnow.gy

First Patient Dosed in CAN108 (Maralixibat) EMBARK Phase 2 Study in Biliary Atresia in China

July 15, 2022

Press release content from Business Wire. The AP news staff was not involved in its creation.

United States James Xue Chris Brinzey Drug Administration Planet Communications Children Hospital Of Capital Institute Pediatrics

Source: apnews.com

First Patient Dosed in CAN108 (Maralixibat) EMBARK Phase 2 Study in Biliary Atresia in China - Press Release

July 15, 2022

China Study is Part of Global EMBARK Study CANbridge Pharmaceuticals Inc. (HKEX:1228), a leading China and US-based global biopharmaceutical company c

United States James Xue Children Hospital Of Capital Institute Pediatrics University Of Washington School Medicine Drug Administration Mirum Pharmaceuticals Inc

Source: wiredprnews.com

China's CANbridge offers treatment for rare liver disease Alagille Syndrome

February 28, 2022

Under the Early and Pilot Implementation Policy in Boao Lecheng International Medical Tourism Pilot Zone

United States James Xue National Medical Products Administration Drug Administration Canbridge Pharmaceuticals Inc Pilot Implementation Policy

Source: biospectrumasia.com

CORRECTING and REPLACING CANbridge Announces Approval of CAN108 for Rare Liver Disease, Alagille Syndrome, Under the Early and Pilot Implementation Policy in Boao Lecheng International Medical Tourism Pilot Zone

February 25, 2022

CORRECTING and REPLACING CANbridge Announces Approval of CAN108 for Rare Liver Disease, Alagille Syndrome, Under the Early and Pilot Implementation Policy in Boao Lecheng International Medical Tourism Pilot Zone - read this article along with other careers information, tips and advice on BioSpace

United States James Xue Pediatr Gastroenterol Nutr Clin Genet Hepatol Comms Mirum Pharmaceuticals

Source: biospace.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation